scholarly article | Q13442814 |
P356 | DOI | 10.1042/CS20120233 |
P698 | PubMed publication ID | 23075332 |
P2093 | author name string | Angela M Carter | |
Victoria R Richardson | |||
Kristina F Standeven | |||
Paul Cordell | |||
P2860 | cites work | Biochemistry and genetics of von Willebrand factor | Q22003890 |
Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII | Q24564521 | ||
Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms | Q28215367 | ||
Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin | Q28245806 | ||
Tissue transglutaminase and its substrates in bone | Q28573074 | ||
Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis | Q28589061 | ||
Regulation of formation of factor XIIIa by its fibrin substrates | Q28630691 | ||
Factor XIII: novel structural and functional aspects | Q30156007 | ||
Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules | Q30419776 | ||
Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. | Q30997344 | ||
Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. | Q33240965 | ||
Does FXIII deficiency impair wound healing after myocardial infarction? | Q33267305 | ||
Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion | Q33387901 | ||
Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis | Q41904806 | ||
Factor XIIIA mobilizes transglutaminase 2 to induce chondrocyte hypertrophic differentiation. | Q41994357 | ||
Reversible activation of cellular factor XIII by calcium | Q42103946 | ||
Analysis of transglutaminase protein substrates by functional proteomics. | Q42141647 | ||
The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking. | Q42326716 | ||
Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade. | Q42955265 | ||
Impaired clot retraction in factor XIII A subunit-deficient mice | Q43227254 | ||
Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface | Q43863360 | ||
Structural features associated with the binding of glutamine-containing peptides to Factor XIII. | Q44137984 | ||
Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets | Q44155386 | ||
Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi | Q44947010 | ||
Molecular mechanism of the interaction between activated factor XIII and its glutamine donor peptide substrate | Q46134154 | ||
Identification of factor-XIIIa-reactive glutaminyl residues in the propolypeptide of bovine von Willebrand factor. | Q46201054 | ||
Megakaryocyte-matrix interaction within bone marrow: new roles for fibronectin and factor XIII-A. | Q46501234 | ||
Clinico-hematologic profile of factor XIII-deficient patients | Q46770303 | ||
Osteopontin, a substrate for transglutaminase and Factor XIII activity | Q46850555 | ||
Vinculin is a permanent component of the membrane skeleton and is incorporated into the (re)organising cytoskeleton upon platelet activation | Q46877736 | ||
Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation | Q47832026 | ||
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. | Q52844285 | ||
Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function. | Q52860308 | ||
Fibrin gel structure: influence of calcium and covalent cross-linking on the elasticity. | Q54288649 | ||
Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen. | Q54325655 | ||
Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A/gamma' fibrinogen. | Q54441943 | ||
Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin. | Q54787975 | ||
Novel Factor XIII Probes for Blood Coagulation Imaging | Q58816212 | ||
Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events | Q33550678 | ||
Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction | Q33789267 | ||
alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study | Q33915670 | ||
Fibronectin at a glance | Q34150530 | ||
Amino acid sequence studies on the .alpha. chain of human fibrinogen. Exact location of crosslinking acceptor sites | Q34229561 | ||
Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. | Q34307809 | ||
Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen | Q34534629 | ||
Identification of intracellular factor XIII in human monocytes and macrophages | Q34548038 | ||
Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi | Q34591264 | ||
TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots | Q34612650 | ||
Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin | Q34707148 | ||
Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen | Q35206931 | ||
Cross-linked gamma-chains in fibrin fibrils bridge 'transversely' between strands: yes. | Q35686021 | ||
Cross-linked gamma-chains in fibrin fibrils bridge transversely between strands: no. | Q35686026 | ||
The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E. | Q35863142 | ||
Alpha2-antiplasmin: potential therapeutic roles in fibrin survival and removal | Q35867311 | ||
Fibrinogen and fibrin. | Q36101288 | ||
The molecular physiology and pathology of fibrin structure/function | Q36166852 | ||
Plasma transglutaminase in hypertrophic chondrocytes: expression and cell-specific intracellular activation produce cell death and externalization | Q36255694 | ||
Coated-platelets: an emerging component of the procoagulant response | Q36272167 | ||
Transglutaminases in mineralized tissues | Q36348212 | ||
The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots | Q36764995 | ||
Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor | Q37020020 | ||
Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa | Q37041474 | ||
The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains | Q37472679 | ||
Fibronectin: structure, function and significance in wound healing | Q37781856 | ||
Covalent cross-linking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin-fibrin matrix | Q38342850 | ||
New insights into the expression and role of platelet factor XIII-A. | Q38354356 | ||
Factor XIIIa-catalyzed cross-linking of recombinant alpha C fragments of human fibrinogen. | Q38357934 | ||
Identification of respective lysine donor and glutamine acceptor sites involved in factor XIIIa-catalyzed fibrin α chain cross-linking | Q40042347 | ||
Expression and localization of plasma transglutaminase factor XIIIA in bone. | Q40162733 | ||
Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. | Q40318405 | ||
Fibronectin: review of its structure and possible functions | Q40354659 | ||
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line. Implications for celiac disease | Q40640779 | ||
Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay | Q40683743 | ||
Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis | Q40684825 | ||
Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking | Q40930403 | ||
Tissue transglutaminase and factor XIII in cartilage and bone remodeling | Q41302285 | ||
Fibrinoligase-catalyzed cross-linking of myosin from platelet and skeletal muscle | Q41538985 | ||
Localization of transglutaminase-reactive glutamine residues in bovine osteopontin. | Q41770359 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | thrombosis | Q261327 |
wound healing | Q1509074 | ||
P304 | page(s) | 123-137 | |
P577 | publication date | 2013-02-01 | |
P1433 | published in | Clinical Science | Q372419 |
P1476 | title | Substrates of Factor XIII-A: roles in thrombosis and wound healing | |
P478 | volume | 124 |
Q37292431 | Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patients |
Q36088633 | Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile. |
Q38562231 | Characterization of a novel large deletion caused by double-stranded breaks in 6-bp microhomologous sequences of intron 11 and 12 of the F13A1 gene |
Q41825512 | Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot |
Q89585538 | Dynamics of coagulation factor XIII activity after video-assisted thoracoscopic lobectomy for non-small cell lung cancer |
Q88104986 | Expression of Coagulation Factor XIII Subunit A Correlates with Outcome in Childhood Acute Lymphoblastic Leukemia |
Q35670403 | Factor XIII Transglutaminase Supports the Resolution of Mucosal Damage in Experimental Colitis |
Q58763233 | Factor XIII polymorphism and risk of aneurysmal subarachnoid haemorrhage in a south Indian population |
Q38561435 | Immune-mediated pathology in Duchenne muscular dystrophy |
Q34436445 | Impact of high prevalence of pseudomonas and polymicrobial gram-negative infections in major sub-/total traumatic amputations on empiric antimicrobial therapy: a retrospective study |
Q86590807 | Longitudinal orientation of cross-linked polypeptide γ chains in fibrin fibrils |
Q28077583 | Molecular Cues Guiding Matrix Stiffness in Liver Fibrosis |
Q91964348 | Prognostic significance of factor XIIIA promoter methylation status in aneurysmal subarachnoid haemorrhage (aSAH) |
Q26739684 | Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting |
Q35156659 | Provisional Matrix Deposition in Hemostasis and Venous Insufficiency: Tissue Preconditioning for Nonhealing Venous Ulcers. |
Q35948493 | Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII. |
Q34481558 | SOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature. |
Q92432047 | Structure functional insights into calcium binding during the activation of coagulation factor XIII A |
Q40827724 | The activation peptide of coagulation factor XIII is vital for its expression and stability. |
Q90316811 | The multifaceted role of fibrinogen in tissue injury and inflammation |
Q34974033 | Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion |
Search more.